肌少症及肌少性肥胖症数据集

肌少症（亦称 “肌肉衰减症”）是以进行性和广泛性的骨骼肌质量及力度下降为特征，可致衰弱、骨折、残疾、感染和死亡率增高等不良临床结局的肌肉相关性疾病。肌少性肥胖症则是肌少症与肥胖并存的一种病症。该数据集涵盖了体格信息、认知能力、行动能力等多维度数据。已有应用场景为分析肌少症与肌少症性肥胖患者疾病分布情况；未来场景是搭建肌少症与肌少症性肥胖诊疗 + 远程随访数字化平台。通过对这些数据的分析，能够深入了解肌少症及肌少性肥胖症患者的特征和健康状况，为这两种疾病的早期筛查、诊断和个性化治疗提供科学依据，也有助于制定针对性的健康干预策略和公共卫生政策，以改善患者的健康结局和生活质量。

Sarcopenia, also known as muscle attenuation, is a muscle-related disorder characterized by progressive and widespread reduction in skeletal muscle mass and strength, which may result in adverse clinical outcomes including frailty, fractures, disability, infections and elevated mortality. Sarcopenic obesity is a clinical condition where sarcopenia coexists with obesity. This dataset encompasses multi-dimensional data such as physical indicators, cognitive function, motor ability and other relevant dimensions. Existing application scenarios include analyzing the disease distribution patterns of patients with sarcopenia and sarcopenic obesity; future application scenarios aim to establish a digital platform for the diagnosis, treatment and remote follow-up of sarcopenia and sarcopenic obesity. Through analysis of this dataset, in-depth insights can be gained into the characteristics and health status of patients with sarcopenia and sarcopenic obesity, providing scientific evidence for early screening, diagnosis and personalized treatment of these two diseases. It also helps to formulate targeted health intervention strategies and public health policies to improve the health outcomes and quality of life of these patients.